Armuzzi, Alessandro
Dettaglio
Armuzzi, Alessandro
ROMA - Dipartimento di Medicina e chirurgia traslazionale
Pubblicazioni
Risultati 1 - 20 di 38 (tempo di esecuzione: 0.001 secondi).
Data di pubblicazione | Titolo | Autore(i) | File | |
---|---|---|---|---|
1 | 2002 | Delta13CO2 excretion and expression of dyspeptic symptoms in patients evaluated for Helicobacter pylori infection by [13C] urea breath test | Franceschi, Francesco; Armuzzi, Alessandro; Cremonini, Filippo; Carloni, Emilia; Zocco, Maria Assunta; Di Caro, Simona; Padalino, Cristiano; Genta, Rm; Pola, Paolo; Gasbarrini, Giovanni Battista; Gasbarrini, Antonio | - |
2 | 2010 | Role of the tumor necrosis factor antagonists in the treatment of inflammatory bowel disease: an update | Leso, Veruscka; Leggio, Lorenzo; Armuzzi, Alessandro; Gasbarrini, Giovanni Battista; Gasbarrini, Antonio; Addolorato, Giovanni | - |
3 | 2006 | Growth hormone in inflammatory bowel disease | De Pascalis, Barbara; Bianchi, A; Satta, Maria Antonia; Lupascu, Andrea; Mentella, Maria Chiara; Leo, Diego; Fiore, F; Fedeli, Paolo; Pontecorvi, Alfredo; Pola, Paolo; Melina, Domenico; Gasbarrini, Antonio; De Marinis, Laura; Armuzzi, Alessandro | - |
4 | 2015 | Management of perianal fistulas in Crohn's disease: an up-to-date review | Marzo, Manuela; Felice, Carla; Pugliese, Daniela; Andrisani, Gianluca; Mocci, Giammarco; Armuzzi, Alessandro; Guidi, Luisa | - |
5 | 2014 | The role of tumour necrosis factor in the pathogenesis of immune-mediated diseases | Blandizzi, C; Gionchetti, P; Armuzzi, Alessandro; Caporali, R; Chimenti, S; Cimaz, R; Cimino, L; Lapadula, G; Lionetti, P; Marchesoni, A; Marcellusi, A; Mennini, Fs; Salvarani, C; Girolomoni, G. | - |
6 | 2013 | Reply to Dr. Joob et al.'s letter | Andrisani, G; Armuzzi, Alessandro | - |
7 | 2013 | Comparison of Quantiferon-TB Gold versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease patients. | Andrisani, Gianluca; Armuzzi, Alessandro; Papa, Alfredo; Marzo, Manuela; Felice, Carla; Pugliese, Daniela; De Vitis, Italo; Rapaccini, Gian Ludovico; Guidi, Luisa | - |
8 | 2013 | Dermatological adverse reactions during anti-TNF treatments: Focus on inflammatory bowel disease. | Mocci, Giammarco; Marzo, Manuela; Papa, Alfredo; Armuzzi, Alessandro; Guidi, Luisa | - |
9 | 2013 | Achievement of sustained deep remission with adalimumab in a patient with both refractory ulcerative colitis and seronegative erosive rheumatoid arthritis | Andrisani, Gianluca; Gremese, Elisa; Guidi, Luisa; Papa, Alfredo; Marzo, Manuela; Felice, Carla; Pugliese, Daniela; Armuzzi, Alessandro | - |
10 | 2013 | A case of pyoderma gangrenosum with ulcerative colitis treated with combined approach: infliximab and surgery | Andrisani, Gianluca; Guidi, Luisa; Papa, Alfredo; Potenza, Ae; Cervelli, D; Armuzzi, Alessandro | - |
11 | 2013 | Reply to Dr. Kotze's and Dr. Yamamoto's letter | Armuzzi, Alessandro; Felice, C. | - |
12 | 2013 | Inducing remission of ulcerative colitis: are clinicians better equipped than ever? | Armuzzi, Alessandro; Felice, C. | - |
13 | 2015 | Clinical trials in ulcerative colitis: a historical perspective | Hindryckx, Pieter; Baert, Filip; Hart, Ailsa; Magro, Fernando; Armuzzi, Alessandro; Peyrin Biroulet, Laurent | - |
14 | 2015 | Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study | Pugliese, Daniela; Guidi, Luisa; Ferraro, Pietro Manuel; Marzo, Manuela; Felice, Carla; Celleno, Leonardo; Landi, Rosario; Andrisani, Gianluca; Pizzolante, Fabrizio; De Vitis, Italo; Papa, Alfredo; Rapaccini, Gian Ludovico; Armuzzi, Alessandro | - |
15 | 2015 | Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's disease | Monteleone, G; Neurath, Mf; Ardizzone, S; Di Sabatino, A; Fantini, Mc; Castiglione, F; Scribano, Ml; Armuzzi, Alessandro; Caprioli, F; Sturniolo, Gc; Rogai, F; Vecchi, M; Atreya, R; Bossa, F; Onali, S; Fichera, M; Corazza, Gr; Biancone, L; Savarino, V; Pica, R; Orlando, A; Pallone, F. | - |
16 | 2015 | Therapeutic drug monitoring of anti-TNF-α agents in inflammatory bowel diseases | Felice, Carla; Marzo, Manuela; Pugliese, Daniela; Papa, Alfredo; Rapaccini, Gian Ludovico; Guidi, Luisa; Armuzzi, Alessandro | - |
17 | 2015 | Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment | Quetglas, Emilio Garcia; Armuzzi, Alessandro; Wigge, S; Fiorino, Gionata; Barnscheid, L; Froelich, M; Danese, Silvio | - |
18 | 2014 | Review article: selective histone deacetylase isoforms as potential therapeutic targets in inflammatory bowel diseases | Felice, C; Lewis, A; Armuzzi, Alessandro; Lindsay, Jo; Silver, A. | - |
19 | 2014 | Anti-TNF alpha in the treatment of ulcerative colitis: a valid approach for organ-sparing or an expensive option to delay surgery? | Rizzo, Gianluca; Pugliese, Daniela; Armuzzi, Alessandro; Coco, Claudio | - |
20 | 2014 | Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis. | Armuzzi, Alessandro; Papa, Alfredo; De Vitis, Italo; Rapaccini, Gian Ludovico; Guidi, Luisa | - |